Health Condition 1: C649- Malignant neoplasm of unspecifiedkidney, except renal pelvis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)ASA grade 1 and 2,Any gender ,Age 20 to 70 years ,BMI 18 to 30 ,Patients willing to participate in the study ,Patients admitted for minimally invasive nephrectomy surgery ,No history of allergy to Local anaesthetics
Exclusion criteria
Exclusion criteria: 1)ASA grade 3, 4, 5,Pregnant and lactating mother,Age less than 20 years and more than 70 years,Obese individuals with BMI more than 30,Chronic history of Opioid abuse,History of allergy to Local anaesthetics,Patients not willing to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)To observe intraoperative Remifentanil requirement and the pain score using Visual Analog Scale (VAS) score for first 24 hours,postoperative Tramadol requirement for first 24 hoursTimepoint: 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) To observe the incidence of hemodynamic disturbances during perioperative period 2) To observe the incidence of side effects of opioids such as postoperative nausea, vomiting, sedation and respiratory depression Timepoint: 12 months | — |
Countries
India
Contacts
SRM INSTITUTES FOR MEDICAL SCIENCES